RecruitingPhase 3NCT03150693
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Sponsor: Alliance for Clinical Trials in Oncology
Atlanta, GA · Augusta, GA · +453 more sites
Leukemia clinical trials in Atlanta, GA
30 recruiting leukemia studies with a site in Atlanta, GA.
RecruitingPhase 2NCT06317662
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Sponsor: National Cancer Institute (NCI)
Atlanta, GA · +114 more sites
RecruitingPhase 1NCT04301076
Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)
Sponsor: National Cancer Institute (NCI)
Atlanta, GA · +17 more sites
RecruitingPhase 1 / Phase 2NCT06137118
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Sponsor: AstraZeneca
Atlanta, GA · +11 more sites
RecruitingPhase 1 / Phase 2NCT04065399
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Sponsor: Syndax Pharmaceuticals
Atlanta, GA · +20 more sites
RecruitingPhase not listedNCT07143669
Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
Sponsor: Blueprint Medicines Corporation
Atlanta, GA · +24 more sites
RecruitingPhase 2NCT06707493
Ivosidenib as Post-HSCT Maintenance for AML
Sponsor: Massachusetts General Hospital
Atlanta, GA · +6 more sites
RecruitingPhase 1NCT07306832
A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Sponsor: AbbVie
Atlanta, GA · +4 more sites
RecruitingPhase 2 / Phase 3NCT07581002
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
Sponsor: AbbVie
Atlanta, GA · +5 more sites
RecruitingPhase 1NCT03802695
A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
Sponsor: Orca Biosystems, Inc.
Atlanta, GA · +11 more sites
RecruitingPhase 2NCT06514794
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
Sponsor: Allotera Therapeutics
Atlanta, GA · +15 more sites
RecruitingPhase 3NCT04293562
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Sponsor: Children's Oncology Group
Atlanta, GA · Augusta, GA · Savannah, GA · +183 more sites
RecruitingPhase 2NCT04996875
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
Sponsor: Cogent Biosciences, Inc.
Atlanta, GA · +13 more sites
RecruitingPhase 1NCT03666000
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
Sponsor: Imugene Limited
Atlanta, GA · +8 more sites
RecruitingPhase 2 / Phase 3NCT03013998
Study of Biomarker-Based Treatment of Acute Myeloid Leukemia
Sponsor: Beat AML, LLC
Atlanta, GA · Augusta, GA · +29 more sites
RecruitingPhase 1 / Phase 2NCT04726241
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Sponsor: PedAL BCU, LLC
Atlanta, GA · Savannah, GA · +162 more sites
RecruitingPhase not listedNCT05702645
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
Sponsor: Children's Oncology Group
Atlanta, GA · Augusta, GA · +70 more sites
RecruitingPhase 1NCT06247787
A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
Sponsor: Children's Oncology Group
Atlanta, GA · +18 more sites
RecruitingPhase 1NCT06001788
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Sponsor: Kura Oncology, Inc.
Atlanta, GA · Augusta, GA · +36 more sites
RecruitingPhase 1NCT05131022
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Sponsor: Nurix Therapeutics, Inc.
Atlanta, GA · +17 more sites
RecruitingPhase 1 / Phase 2NCT04068597
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
Sponsor: CellCentric Ltd.
Atlanta, GA · +5 more sites
RecruitingPhase 1NCT05768932
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia
Sponsor: SillaJen, Inc.
Atlanta, GA · +10 more sites
RecruitingPhase not listedNCT05978141
A Registry for People With T-cell Lymphoma
Sponsor: Memorial Sloan Kettering Cancer Center
Atlanta, GA · +25 more sites
RecruitingPhase not listedNCT01790152
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
Sponsor: Children's Oncology Group
Atlanta, GA · +68 more sites
RecruitingPhase 1NCT03633955
Pilot Imaging Study of Leukemia
Sponsor: University of Oklahoma
Atlanta, GA · +2 more sites
RecruitingPhase 1NCT05292664
Venetoclax Basket Trial for High Risk Hematologic Malignancies
Sponsor: Andrew E. Place, MD
Atlanta, GA · +4 more sites
RecruitingPhase 4NCT06876649
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Sponsor: Eli Lilly and Company
Atlanta, GA · +19 more sites
RecruitingPhase 1NCT04872478
Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL
Sponsor: Meryx, Inc.
Atlanta, GA · +1 more sites
RecruitingPhase 1NCT06366789
Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia
Sponsor: Lomond Therapeutics Holdings, Inc.
Atlanta, GA · +11 more sites
Not yet recruitingPhase 1NCT07511062
Axatilimab Combined With Decitabine/Venetoclax for the Treatment of TP53-mutated AML
Sponsor: Northside Hospital, Inc.
Atlanta, GA
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.